KBC Group’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$74K Hold
3,597
﹤0.01% 1486
2025
Q4
$85K Hold
3,597
﹤0.01% 1393
2025
Q3
$90K Hold
3,597
﹤0.01% 1331
2025
Q2
$83K Sell
3,597
-1,415
-28% -$32.8K ﹤0.01% 1322
2025
Q1
$113K Hold
5,012
﹤0.01% 1414
2024
Q4
$98K Buy
5,012
+1,627
+48% +$32.2K ﹤0.01% 1570
2024
Q3
$62K Buy
3,385
+871
+35% +$16.6K ﹤0.01% 1614
2024
Q2
$44K Hold
2,514
﹤0.01% 1695
2024
Q1
$49K Hold
2,514
﹤0.01% 1574
2023
Q4
$58K Sell
2,514
-344
-12% -$7.7K ﹤0.01% 1413
2023
Q3
$66K Sell
2,858
-4,520
-61% -$115K ﹤0.01% 1236
2023
Q2
$193K Buy
+7,378
New +$195K ﹤0.01% 950

Other funds holding PRVA

KBC Group's PRVA Position: Q1 2026 in Review

KBC Group held its Privia Health (PRVA) position steady in Q1 2026 at 3,597 shares worth $74K. The position accounts for ﹤0.01% of the portfolio, ranked #1486.

KBC Group first reported a position in PRVA in Q2 2023 and has held it in 12 quarters since. The position peaked at $193K in Q2 2023. 293 funds tracked by Wall St. Rank hold PRVA as of Q1 2026.

  • KBC Group held 3,597 shares of Privia Health worth $74K as of Q1 2026.
  • KBC Group left its Privia Health share count unchanged in Q1 2026.
  • Privia Health made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #1486 holding.
  • KBC Group first reported a position in Privia Health in Q2 2023 and has held it in 12 quarters since.
  • KBC Group's Privia Health position peaked at $193K in Q2 2023.
  • 293 funds tracked by Wall St. Rank held Privia Health as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.